Send us Feedback

ACADIA Pharmaceuticals (ACAD)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
ACADIA Pharmaceuticals to Webcast Educational Program on Parkinson’s Disease Psychosis on May 22, 2012
Business Wire  May 15  Comment 
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will host a live webcast
Acadia Pharmaceuticals, Inc. (ACAD) Posts Q1 Loss of 12c/Share
StreetInsider.com  May 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Acadia+Pharmaceuticals%2C+Inc.+%28ACAD%29+Posts+Q1+Loss+of+12cShare/7416001.html for the full story.
ACADIA Pharmaceuticals Reports First Quarter 2012 Financial Results
Business Wire  May 8  Comment 
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results
ACADIA Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 8, 2012
Business Wire  May 1  Comment 
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited
UPDATE: Ladenburg Thalmann Initiates Coverage on Acadia Pharmaceuticals
Benzinga  Apr 30  Comment 
According to a research report published this morning, Ladenburg Thalmann has initiated Acadia Pharmaceuticals (NASDAQ: ACAD) with a Buy rating. In the report, Ladenburg Thalmann said, "Our investment thesis rests on the prospects of...
ACADIA Pharmaceuticals to Present at the 19th Annual Future Leaders in the Biotech Industry Conference on April 20, 2012
Business Wire  Apr 13  Comment 
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the 19th
ACADIA Pharmaceuticals Awarded New Grant from The Michael J. Fox Foundation for Development of Nurr1-RXR Selective Agonists to Treat Parkinson’s Disease
Business Wire  Mar 27  Comment 
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has been awarded a new
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2011
Business Wire  Mar 6  Comment 
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced its financial results for the
ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan, Inc.
Business Wire  Mar 5  Comment 
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has extended its drug
ACADIA Pharma (ACAD), Allergan (AGN) Expand Ophthalmic Indication Discovery Collaboration
StreetInsider.com  Mar 5  Comment 
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
Business Wire  Feb 29  Comment 
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/ACADIA_Pharmaceuticals_(ACAD)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki